Finabank N.V.

RATING ACTION:

 On September 20, 2024, CariCRIS reaffirmed the Issuer/Corporate Credit Ratings assigned to Finabank N.V. (Finabank or the Bank) at srA (Foreign Currency Rating) and srA+ (Local Currency Rating) on the Suriname national scale. A stable outlook was maintained. 

RATING SENSITIVITY FACTORS:

 Factors that could, individually or collectively, lead to an improvement in the ratings and/or outlook include:

  • Improvement in the Government of Suriname’s (GOS’) credit risk profile, leading to an improved economic and business environment for Finabank
  • Retail deposits ≥ 40% of funding base
  • A greater than 100% increase in Profit After Tax (PAT) sustained for 2 consecutive financial years
  • Improvement in Tangible Net Worth (TNW) to total adjusted assets to 12% or above sustained for 2 consecutive financial years

Factors that could, individually or collectively, lead to a lowering of the ratings and/or outlook include:

  • Deterioration in the GOS’ credit risk profile, leading to a worsened economic and business environment for Finabank
  • Deterioration of the gross Non-Performing Loans (NPLs) to gross loans ratio to 5% or more, leading to reduced earnings and increased provisioning, thereby affecting profitability
  • Cost to income ≥ 50% sustained for 2 consecutive financial years
  • A greater than 10% decline in total income sustained for 2 consecutive financial years
  • The occurrence of any factors that may contribute to the deterioration of the Capital Adequacy Ratio (CAR) below the 10% minimum requirement for the Bank

 

Analysts’ Contact Info:

Keith Hamlet
Mobile: 1-868-487-8356
[email protected]

Megan Dass
Mobile: 1-868-713-6863
[email protected]

www.caricris.com
[email protected]

Disclaimer: CariCRIS has taken due care and caution in compilation of data for this product. Information has been obtained by CariCRIS from sources which it considers reliable. However, CariCRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. No part of this report may be published/ reproduced in any form without CariCRIS’ prior written approval. CariCRIS is also not responsible for any errors in transmission and especially states that it has no financial liability whatsoever to the subscribers/ users/ transmitters/ distributors of this product.